Artem Pinkhasov, PA-C

Artem Pinkhasov practices at Skin First Dermatology in New York, New York.

Artem Pinkhasov's NPI, 1740527845, was assigned on January 9, 2013. Artem Pinkhasov holds New York license 0162681.

Artem Pinkhasov's primary practice is Skin First Dermatology, at 601 W 163rd St, New York, NY 10032-5632. The practice phone is (212) 433-0700.

Artem Pinkhasov's primary practice is Skin First Dermatology in New York, New York. The medical group on file is Skin First Dermatology.

Dmand AI tracks the electronic health record (EHR) system at each site where Artem Pinkhasov practices. Vendor and product names are available with a free account.

Surgical is Artem Pinkhasov's primary specialty in the NPI Registry, under taxonomy code 363AS0400X. Artem Pinkhasov is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Artem Pinkhasov is licensed in New York.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, hives, scalp rash and skin cyst among the conditions Artem Pinkhasov treats.

CMS data shows 505 Medicare services from Artem Pinkhasov across 11 procedure codes in 2024, for 76 Medicare patients. Medicare paid $28,914 for them. Every service was in an office.

CMS counts 76 Medicare patients who saw Artem Pinkhasov in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 28% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Artem Pinkhasov's median patient age at 38, with 58% women.

In 2024, Artem Pinkhasov wrote 934 Medicare Part D claims for 270 patients. 84% of them were for generic drugs. CMS names the drug for 768 of them, across 17 drugs with 11 or more claims each, at $200,349 in total drug cost.

Artem Pinkhasov accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 15 general payments to Artem Pinkhasov from 6 drug and device companies in 2025. Food and beverage make up the largest share, 82% of the total. Incyte Corporation paid the most, $197.